{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:02:12Z","timestamp":1768316532092,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,22]]},"DOI":"10.7759\/cureus.31799","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T01:52:40Z","timestamp":1669168360000},"source":"Crossref","is-referenced-by-count":2,"title":["A Review on Major Pathways Leading to Peritoneal Fibrosis in Patients Receiving Continuous Peritoneal Dialysis"],"prefix":"10.7759","author":[{"given":"Sogand","family":"Taheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvedha S","family":"Thiagaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Twisha S","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Dheeraj","family":"Gutlapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanmani","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namratha","family":"Pallipamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-018-00455-2","article-title":"Cost effectiveness of dialysis modalities: a systematic review of economic evaluations","volume":"17","author":"Howell M","year":"2019","unstructured":"Howell M, Walker RC, Howard K. Cost effectiveness of dialysis modalities: a systematic review of economic evaluations. Appl Health Econ Health Policy. 2019, 17:315-30. 10.1007\/s40258-018-00455-2","journal-title":"Appl Health Econ Health Policy"},{"key":"ref2","unstructured":"Peritoneal dialysis. (2020). Accessed. 07\/15\/2022: https:\/\/www.merckmanuals.com\/professional\/genitourinary-disorders\/renal-replacement-therapy\/peritoneal-dialysis#top."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv295","article-title":"Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period","volume":"31","author":"van de Luijtgaarden MW","year":"2016","unstructured":"van de Luijtgaarden MW, Jager KJ, Segelmark M, et al.. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant. 2016, 31:120-8. 10.1093\/ndt\/gfv295","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2064304","article-title":"Artificial intelligence in peritoneal dialysis: general overview","volume":"44","author":"Bai Q","year":"2022","unstructured":"Bai Q, Tang W. Artificial intelligence in peritoneal dialysis: general overview. Ren Fail. 2022, 44:682-7. 10.1080\/0886022X.2022.2064304","journal-title":"Ren Fail"},{"key":"ref5","article-title":"Advances in peritoneal dialysis","volume":"59","author":"Krediet RT","year":"2007","unstructured":"Krediet RT. Advances in peritoneal dialysis. Minerva Urol Nefrol. 2007, 59:251-60.","journal-title":"Minerva Urol Nefrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157955","article-title":"How to improve the biocompatibility of peritoneal dialysis solutions (without jeopardizing the patient\u2019s health)","volume":"22","author":"Bonomini M","year":"2021","unstructured":"Bonomini M, Masola V, Procino G, Zammit V, Divino-Filho JC, Arduini A, Gambaro G. How to improve the biocompatibility of peritoneal dialysis solutions (without jeopardizing the patient\u2019s health). Int J Mol Sci. 2021, 22:7955. 10.3390\/ijms22157955","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i28.3101","article-title":"Encapsulating peritoneal sclerosis","volume":"24","author":"Danford CJ","year":"2018","unstructured":"Danford CJ, Lin SC, Smith MP, Wolf JL. Encapsulating peritoneal sclerosis. World J Gastroenterol. 2018, 24:3101-11. 10.3748\/wjg.v24.i28.3101","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.925341","article-title":"Encapsulating peritoneal sclerosis: a case report and literature review","volume":"21","author":"Al-Lawati AI","year":"2020","unstructured":"Al-Lawati AI, Al Shaibi M, Al Mahruqi G, et al.. Encapsulating peritoneal sclerosis: a case report and literature review. Am J Case Rep. 2020, 21:e925341. 10.12659\/AJCR.925341","journal-title":"Am J Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10122585","article-title":"Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis","volume":"10","author":"Morgera S","year":"1999","unstructured":"Morgera S, Kuchinke S, Budde K, Lun A, Hocher B, Neumayer HH. Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1999, 10:2585-90. 10.1681\/ASN.V10122585","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.950933","article-title":"Corrigendum: aging of the peritoneal dialysis membrane","volume":"13","author":"Krediet RT","year":"2022","unstructured":"Krediet RT. Corrigendum: aging of the peritoneal dialysis membrane. Front Physiol. 2022, 13:950933. 10.3389\/fphys.2022.950933","journal-title":"Front Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109778","article-title":"Molecular pathways in peritoneal fibrosis","volume":"75","author":"Balzer MS","year":"2020","unstructured":"Balzer MS. Molecular pathways in peritoneal fibrosis. Cell Signal. 2020, 75:109778. 10.1016\/j.cellsig.2020.109778","journal-title":"Cell Signal"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams JD","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, et al.. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002, 13:470-9. 10.1681\/ASN.V132470","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070799","article-title":"A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis","volume":"26","author":"Busnadiego O","year":"2015","unstructured":"Busnadiego O, Loureiro-\u00c1lvarez J, Sandoval P, et al.. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol. 2015, 26:173-82. 10.1681\/ASN.2013070799","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00052.2017","article-title":"TGF-\u03b21-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis","volume":"314","author":"Kariya T","year":"2018","unstructured":"Kariya T, Nishimura H, Mizuno M, et al.. TGF-\u03b21-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis. Am J Physiol Renal Physiol. 2018, 314:F167-80. 10.1152\/ajprenal.00052.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref15","article-title":"High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation","volume":"19","author":"Kang DH","year":"1999","unstructured":"Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit Dial Int. 1999, 19:221-30.","journal-title":"Perit Dial Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01652-x","article-title":"Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis","volume":"4","author":"Li YC","year":"2021","unstructured":"Li YC, Sung PH, Yang YH, Chiang JY, Yip HK, Yang CC. Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis. Commun Biol. 2021, 4:144. 10.1038\/s42003-021-01652-x","journal-title":"Commun Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000291","article-title":"Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects","volume":"26","author":"Takagaki Y","year":"2017","unstructured":"Takagaki Y, Koya D, Kanasaki K. Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects. Curr Opin Nephrol Hypertens. 2017, 26:56-66. 10.1097\/MNH.0000000000000291","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.13","article-title":"An update on peritoneal dialysis solutions","volume":"8","author":"Garc\u00eda-L\u00f3pez E","year":"2012","unstructured":"Garc\u00eda-L\u00f3pez E, Lindholm B, Davies S. An update on peritoneal dialysis solutions. Nat Rev Nephrol. 2012, 8:224-33. 10.1038\/nrneph.2012.13","journal-title":"Nat Rev Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr580","article-title":"Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis","volume":"27","author":"Han SH","year":"2012","unstructured":"Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis. Nephrol Dial Transplant. 2012, 27:2044-50. 10.1093\/ndt\/gfr580","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007554.pub3","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"10","author":"Htay H","year":"2018","unstructured":"Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2018, 10:CD007554. 10.1002\/14651858.CD007554.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.04.007","article-title":"Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial","volume":"62","author":"Bonomini M","year":"2013","unstructured":"Bonomini M, Di Liberato L, Del Rosso G, et al.. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. Am J Kidney Dis. 2013, 62:929-38. 10.1053\/j.ajkd.2013.04.007","journal-title":"Am J Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094739","article-title":"Effects of TGF-\u03b21 receptor inhibitor GW788388 on the epithelial to mesenchymal transition of peritoneal mesothelial cells","volume":"22","author":"Lho Y","year":"2021","unstructured":"Lho Y, Do JY, Heo JY, Kim AY, Kim SW, Kang SH. Effects of TGF-\u03b21 receptor inhibitor GW788388 on the epithelial to mesenchymal transition of peritoneal mesothelial cells. Int J Mol Sci. 2021, 22:4739. 10.3390\/ijms22094739","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/path.5101","article-title":"Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses","volume":"245","author":"Namvar S","year":"2018","unstructured":"Namvar S, Woolf AS, Zeef LA, Wilm T, Wilm B, Herrick SE. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses. J Pathol. 2018, 245:491-501. 10.1002\/path.5101","journal-title":"J Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira LS","year":"2007","unstructured":"Aroeira LS, Aguilera A, S\u00e1nchez-Tomero JA, et al.. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007, 18:2004-13. 10.1681\/ASN.2006111292","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114158","article-title":"Reprogramming of mesothelial-mesenchymal transition in chronic peritoneal diseases by estrogen receptor modulation and TGF-\u03b21 inhibition","volume":"21","author":"Wilson RB","year":"2020","unstructured":"Wilson RB, Archid R, Reymond MA. Reprogramming of mesothelial-mesenchymal transition in chronic peritoneal diseases by estrogen receptor modulation and TGF-\u03b21 inhibition. Int J Mol Sci. 2020, 21:4158. 10.3390\/ijms21114158","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092487","article-title":"Roles of the TGF-\u03b2\u207bVEGF-C pathway in fibrosis-related lymphangiogenesis","volume":"19","author":"Kinashi H","year":"2018","unstructured":"Kinashi H, Ito Y, Sun T, Katsuno T, Takei Y. Roles of the TGF-\u03b2\u207bVEGF-C pathway in fibrosis-related lymphangiogenesis. Int J Mol Sci. 2018, 19:2487. 10.3390\/ijms19092487","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M211304200","article-title":"Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions","volume":"278","author":"Peinado H","year":"2003","unstructured":"Peinado H, Quintanilla M, Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem. 2003, 278:21113-23. 10.1074\/jbc.M211304200","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0335-0","article-title":"Nintedanib: first global approval","volume":"75","author":"McCormack PL","year":"2015","unstructured":"McCormack PL. Nintedanib: first global approval. Drugs. 2015, 75:129-39. 10.1007\/s40265-014-0335-0","journal-title":"Drugs"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16518","article-title":"Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis","volume":"25","author":"Liu F","year":"2021","unstructured":"Liu F, Yu C, Qin H, et al.. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis. J Cell Mol Med. 2021, 25:6103-14. 10.1111\/jcmm.16518","journal-title":"J Cell Mol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934158","article-title":"Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity","volume":"68","author":"Parikova A","year":"2019","unstructured":"Parikova A, Hruba P, Krediet RT, Krejcik Z, Stranecky V, Striz I, Viklicky O. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. Physiol Res. 2019, 68:775-83. 10.33549\/physiolres.934158","journal-title":"Physiol Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101361","article-title":"IL-17A as a potential therapeutic target for patients on peritoneal dialysis","volume":"10","author":"Marchant V","year":"2020","unstructured":"Marchant V, Tejera-Mu\u00f1oz A, Marquez-Exp\u00f3sito L, et al.. IL-17A as a potential therapeutic target for patients on peritoneal dialysis. Biomolecules. 2020, 10:1361. 10.3390\/biom10101361","journal-title":"Biomolecules"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.33","article-title":"IL-17A is a novel player in dialysis-induced peritoneal damage","volume":"86","author":"Rodrigues-D\u00edez R","year":"2014","unstructured":"Rodrigues-D\u00edez R, Aroeira LS, Orejudo M, et al.. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int. 2014, 86:303-15. 10.1038\/ki.2014.33","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"Mi S","year":"2011","unstructured":"Mi S, Li Z, Yang HZ, et al.. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol. 2011, 187:3003-14. 10.4049\/jimmunol.1004081","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080923","article-title":"Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis","volume":"28","author":"Raby AC","year":"2017","unstructured":"Raby AC, Colmont CS, Kift-Morgan A, et al.. Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol. 2017, 28:461-78. 10.1681\/ASN.2015080923","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119099-a-review-on-major-pathways-leading-to-peritoneal-fibrosis-in-patients-receiving-continuous-peritoneal-dialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:34Z","timestamp":1707507754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119099-a-review-on-major-pathways-leading-to-peritoneal-fibrosis-in-patients-receiving-continuous-peritoneal-dialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.31799","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}